Vanderbilt University School of Engineering

October 24, 2019

Pietenpol, Wilson land Komen cancer research support

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

By Tom Wilemon
October 16, 2019

New app to help pediatricians recognize autism risk in young children

Researchers have been awarded $1 million from the National Institute of Mental Health to evaluate a new mobile app designed to help pediatricians recognize autism risk in young children.

By Kelsey Herbers
March 14, 2019

Cancer Center Ambassadors surpass $1 million in grants

Vanderbilt-Ingram Cancer Center Ambassadors surpassed the $1 million mark with the awarding of the group’s latest research grants.

By Tom Wilemon
Rene Gifford, PhD, works with patient Davy Hillis to program his cochlear implant.
February 21, 2019

Study takes personal approach to cochlear implant programming

Vanderbilt University Medical Center recently received a $3.9 million grant from the National Institutes of Health (NIH) to improve outcomes for children with significant hearing loss by providing individualized, prescription-like programming for their cochlear implants.

By Kelsey Herbers
Elderly caucasian woman with her hands on a cane
February 12, 2018

‘Smart cane’ could one day help flag gait problems, falling risks more quickly

Falling is no joke when you’re a senior citizen or have other balance issues. Vanderbilt engineers are working on a ‘smart cane’ that could help physical therapists spot and treat problems sooner.

By VUMC News and Communications
April 3, 2017

Vanderbilt investigator lands Stand Up To Cancer grant for “smart” nanoparticles cancer research

John Wilson, Ph.D., assistant professor of Chemical and Biomolecular Engineering and of Biomedical Engineering at Vanderbilt University, has received an Innovative Research Grant from Stand Up To Cancer (SU2C). Wilson is among 10 early-career scientists to receive the grant awards focused on immuno-oncology.

April 8, 2015

Micelle “packets” deliver cancer drugs

Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells.
By VUMC News and Communications
April 17, 2014

Competition showcases commercial viability of ideas

A strategy for commercializing an optical 3-D scanner that can ensure all cancerous breast tissue is removed during surgery, thereby avoiding the need for a second operation, has won top honors at this year’s TechVenture Challenge.
By Bill Snyder
September 11, 2013

Vanderbilt Medicine: Robotics revolution

In the foreseeable future, robots will be sticking steerable needles in your brain to remove blood clots; capsule robots will be crawling up your colon as a painless replacement for the colonoscopy; and ultra-miniaturized snake robots will remove tumors from your bladder and other body cavities.
By VUMC News and Communications
March 23, 2013

Humanoid robot helps train children with autism

An interdisciplinary team of mechanical engineers and autism experts at Vanderbilt University have developed an adaptive robotic system and used it to demonstrate that humanoid robots can be powerful tools for enhancing the basic social learning skills of children with autism.
By VUMC News and Communications
March 5, 2013

High Fidelity: Cochlear implant users report dramatically better hearing with new Vanderbilt process

Longtime cochlear implant users are reporting such dramatic improvements in their hearing, thanks to new image-guided programming methods developed by Vanderbilt University researchers.
By VUMC News and Communications
September 28, 2011

New group of faculty endowed chairs celebrated

Ten of Vanderbilt’s new endowed chairs were praised as leaders in their fields and on campus during a Sept. 26 ceremony at the Student Life Center.
By VUMC News and Communications
April 4, 2011

Better tools needed to target autism treatments for children

Although an evaluation of existing treatments for children with autism spectrum disorders found positive results in some studies, better information is needed to target the right treatments to specific children.
By Craig Boerner